- NCT00060502
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameInfliximabProduct NameREMICADE®Therapeutic AreaImmune System DiseasesEnrollment73% Female46.1%% White98.9%
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberC0168T60Data PartnerJohnson & JohnsonCondition StudiedCachexiaMean/Median Age (Years)63.1
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available